|
⚲
|
| Keyboard |
| Vida Ventures II-A LLC
✚
|
|
|---|---|
| CIK # | 0001781930 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001781930] | |
| 4 | [0001781930] | |
| D | [0001781930] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Vida Ventures II-A LLC | |
| Vida Ventures II LLC | |
| Aktis Oncology Inc | |
| Dyne Therapeutics Inc | |
| VV Manager II LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aktis Oncology Inc AKTS
Series B Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 3,648,750 | $0.00 | |
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Buy | 22,545 | $18.00 | 405,810 |
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Conversion | 134,842 | ||
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Buy | 812,455 | $18.00 | 14,624,190 |
|
Aktis Oncology Inc AKTS
Series A Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 14,838,250 | $0.00 | |
|
Aktis Oncology Inc AKTS
Series A Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 411,750 | $0.00 | |
|
Aktis Oncology Inc AKTS
Series B Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 101,250 | $0.00 | |
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Conversion | 4,859,370 | ||
|
Dyne Therapeutics Inc DYN
Common Stock
|
2020-09-21 | Buy | 792,995 | $19.00 | 15,066,905 |
|
Dyne Therapeutics Inc DYN
Common Stock
|
2020-09-21 | Buy | 22,005 | $19.00 | 418,095 |
|
Dyne Therapeutics Inc DYN
Common Stock
|
2020-09-21 | Conversion | 2,087,130 | ||
|
Dyne Therapeutics Inc DYN
Series B Preferred Stock · derivative
|
2020-09-21 | Conversion | 192,102 | $0.00 | |
|
Dyne Therapeutics Inc DYN
Series B Preferred Stock · derivative
|
2020-09-21 | Conversion | 6,922,803 | $0.00 | |
|
Dyne Therapeutics Inc DYN
Common Stock
|
2020-09-21 | Conversion | 57,916 |